Obesity Clinical Trial
Official title:
Testing a Healthy Weight Intervention in Adolescents
Few obesity prevention programs have produced weight gain prevention effects that persist
over long-term follow-up and those that have are extremely lengthy, averaging 52 hr in
duration, making implementation difficult and costly. The 2010 US Preventative Services Task
Force (USPSTF) recommendations for treating child & adolescent obesity state that programs
should have ≥ 25 hr of comprehensive treatment including dietary, physical activity and
behavioral counseling, and that programs with < 25 hr usually do not produce improvements.
The implication is that, if centers cannot provide this level of service (as most cannot),
it is not worth providing any kind of treatment at all. In extreme exception to this, an
intensive 3-hr non-restrictive obesity prevention program involving participant-driven
healthy lifestyle improvement plans designed to bring caloric intake and output into balance
(Healthy Weight) has been found to significantly reduce increases in BMI and obesity onset
relative to alternative interventions and assessment-only controls through 3-yr follow-up.
We propose to test an extended 6-hr version of the Healthy Weight intervention in a sample
of primarily low SES, minority adolescents and young adults who are overweight and report
body dissatisfaction and subthreshold eating disorder symptoms, as these are prevalent risk
factors for obesity. We will test the hypothesis that participants assigned to the Healthy
Weight vs. control intervention will have significantly lower BMI and % body fat during
follow-up. Secondary outcomes will include body dissatisfaction, depressive symptoms, and
eating disorder symptoms. 300 adolescents and young adults at high risk for future weight
gain by virtue of their age, BMI percentile, body dissatisfaction and eating disorder
symptomatology will be randomized to Healthy Weight or weight control educational video.
Participants will complete assessments of BMI, body composition, potential mediators, and
other outcomes at pretest, posttest and 6--mo follow-ups (in yr 1). Thus, to refute the
USPSTF recommendations statement, we propose to show that a 6-hr intervention led by
graduate students can produce significant reductions in risk for both obesity and eating
disorders, suggesting this inexpensive and brief intervention could and should be rolled out
nationwide.
Primary Aim: To test the hypothesis that Healthy Weight will significantly reduce increases
in BMI, % body fat, and risk for onset of obesity during follow-up.
Secondary Aim: To test the hypothesis that Healthy Weight will significantly reduce body
dissatisfaction, depressive symptoms, and eating disorder symptoms.
NOTE: THIS STUDY IS ONLY OPEN TO PATIENTS AT THE MOUNT SINAI ADOLESCENT HEALTH CENTER
Status | Terminated |
Enrollment | 80 |
Est. completion date | September 2015 |
Est. primary completion date | September 2015 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 12 Years to 24 Years |
Eligibility |
Inclusion Criteria: - = 12 years old - Body image concerns - Sub-threshold Eating disorder symptomatology - Overweight but not obese (BMI between the 85th and 95th percentile for children/adolescents and BMI between 25 and 30 kg/m2 for adults 21-24) - Be able to commit to weekly 1-hour sessions for six weeks and 3 separate assessment visits to the MSAHC Exclusion Criteria: - Current eating disorder (anorexia nervosa, bulimia nervosa or binge eating disorder) - absence of body image concerns - normal or obese body weight (< 85th or = 95th BMI percentile) |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Investigator, Outcomes Assessor), Primary Purpose: Prevention
Country | Name | City | State |
---|---|---|---|
United States | Icahn School of Medicine at Mount Sinai | New York | New York |
Lead Sponsor | Collaborator |
---|---|
Icahn School of Medicine at Mount Sinai |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Body Mass Index (BMI) | Height will be measured to the nearest millimeter using a direct reading stadiometer. Weight will be assessed to the nearest 0.1 kg using a digital scale (Tanita TBF-300A) with participants wearing light clothing without shoes or coats. | baseline | No |
Primary | Body Mass Index (BMI) | Height will be measured to the nearest millimeter using a direct reading stadiometer. Weight will be assessed to the nearest 0.1 kg using a digital scale (Tanita TBF-300A) with participants wearing light clothing without shoes or coats. | at 5 min post intervention | No |
Primary | Body Mass Index (BMI) | Height will be measured to the nearest millimeter using a direct reading stadiometer. Weight will be assessed to the nearest 0.1 kg using a digital scale (Tanita TBF-300A) with participants wearing light clothing without shoes or coats. | 6 month follow-up | No |
Primary | Body Fat | Body Fat - We will use bioelectrical impedance analysis (BIA) using the Tanita TBF-300A Body Composition Analyzer to assess % body fat to maximize our sensitivity to predict increases in body fat and obesity onset. Two measures will be averaged. | baseline | No |
Primary | Body Fat | Body Fat - We will use bioelectrical impedance analysis (BIA) using the Tanita TBF-300A Body Composition Analyzer to assess % body fat to maximize our sensitivity to predict increases in body fat and obesity onset. Two measures will be averaged. | at 5 min post intervention | No |
Primary | Body Fat | Body Fat - We will use bioelectrical impedance analysis (BIA) using the Tanita TBF-300A Body Composition Analyzer to assess % body fat to maximize our sensitivity to predict increases in body fat and obesity onset. Two measures will be averaged. | 6 month follow up | No |
Secondary | Body Dissatisfaction | an adapted form of the Satisfaction and Dissatisfaction with Body Parts Scale to assess body satisfaction (Berscheid et al., 1973). It asks respondents to rate their level of satisfaction with nine body parts on 6-point scales ranging from "extremely satisfied" to "extremely dissatisfied." This scale has shown excellent internal consistency, temporal reliability, predictive validity for eating disorder symptom onset, and sensitivity to intervention effects (Stice et al., 2006; 2008; 2012). | baseline | No |
Secondary | Body Dissatisfaction | an adapted form of the Satisfaction and Dissatisfaction with Body Parts Scale to assess body satisfaction (Berscheid et al., 1973). It asks respondents to rate their level of satisfaction with nine body parts on 6-point scales ranging from "extremely satisfied" to "extremely dissatisfied." This scale has shown excellent internal consistency, temporal reliability, predictive validity for eating disorder symptom onset, and sensitivity to intervention effects (Stice et al., 2006; 2008; 2012). | at 5 min post intervention | No |
Secondary | Body Dissatisfaction | an adapted form of the Satisfaction and Dissatisfaction with Body Parts Scale to assess body satisfaction (Berscheid et al., 1973). It asks respondents to rate their level of satisfaction with nine body parts on 6-point scales ranging from "extremely satisfied" to "extremely dissatisfied." This scale has shown excellent internal consistency, temporal reliability, predictive validity for eating disorder symptom onset, and sensitivity to intervention effects (Stice et al., 2006; 2008; 2012). | at 6 months follow up | No |
Secondary | Eating Disorders | baseline | No | |
Secondary | Eating Disorders | at 5 min post intervention | No | |
Secondary | Eating Disorders | at 6 months follow up | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |